Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Asset Writedowns and Impairment (2023 - 2025)

BioNexus Gene Lab's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $55269.0 for Q4 2025.

  • Quarterly results put Asset Writedowns and Impairment at $55269.0 for Q4 2025, up 147.44% from a year ago — trailing twelve months through Dec 2025 was $116962.0 (up 198.95% YoY), and the annual figure for FY2025 was $271211.0, up 4175.08%.
  • Asset Writedowns and Impairment for Q4 2025 was $55269.0 at BioNexus Gene Lab, down from $175818.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $175818.0 in Q3 2025 to a low of -$116499.0 in Q4 2024.
  • The 3-year median for Asset Writedowns and Impairment is $1235.5 (2023), against an average of $18814.0.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 2690.4% in 2024, then skyrocketed 7305.98% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at -$4175.0 in 2023, then plummeted by 2690.4% to -$116499.0 in 2024, then skyrocketed by 147.44% to $55269.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $55269.0, $175818.0, and -$116499.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.